Sen. Cotton's ABC Safe Drug Act Would Bar Federal Health Programs From Buying Chinese-Made Drug Ingredients
A senate committee must act next: committee consideration.
No action since April 2025
Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
The Department of Defense is explicitly covered by the bill's purchasing restrictions. Active-duty service members receive medications through military health systems like TRICARE. The transition away from Chinese-sourced drug ingredients aims to strengthen national security but could temporarily affect drug availability or costs within military healthcare.
Read twice and referred to the Committee on Finance.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
No votes or related bills recorded for this bill yet.
Document Type
Congressional Bill
Official Title
ABC Safe Drug Act
Analysis generated by AI. Always verify with official sources.